コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 actin-nucleating machine activated by WASp (Wiskott Aldrich syndrome protein).
2 n with the nucleation-promoting factor Wasp (Wiskott-Aldrich syndrome protein).
3 fining mechanisms that control activation of Wiskott-Aldrich syndrome protein.
4 se 1, Grb2-associated protein 2 (Grap2), and Wiskott-Aldrich syndrome protein.
5 ft microdomain along with Arp2/3 complex and Wiskott-Aldrich syndrome protein.
6 ing edges of lamellipodia, Arp3 and neuronal Wiskott-Aldrich syndrome protein.
7 Cdc42 using the GTPase-binding domain of the Wiskott-Aldrich syndrome protein.
8 adhesion kinase, Rho GTPase Rac1, and neural Wiskott-Aldrich syndrome protein.
9 e cytoskeleton by binding and activating the Wiskott-Aldrich syndrome protein.
10 suring vector copy numbers and expression of Wiskott-Aldrich syndrome protein.
11 ngagement increases actin polymerization and Wiskott-Aldrich syndrome protein activation in a Btk-dep
12 achment but inhibits ingestion by decreasing Wiskott-Aldrich syndrome protein activation, and hence a
13 as the levels of F-actin and phosphorylated Wiskott Aldrich syndrome protein, an actin nucleation pr
14 r binding to the SH3 domains with the neural Wiskott-Aldrich Syndrome protein, an actin filament nucl
15 exists in a macromolecular complex with the Wiskott-Aldrich syndrome protein, an actin nucleation-pr
16 rmore, syndapin I associates with the neural Wiskott-Aldrich syndrome protein, an actin-depolymerizin
18 e Cdc42-binding domains of the CRIB motif of Wiskott-Aldrich Syndrome protein and p21(cdc42/rac)-acti
19 contractility, independent of its effects on Wiskott-Aldrich syndrome protein and p21-activated kinas
20 lled strumpellin, is a core component of the Wiskott-Aldrich syndrome protein and SCAR homolog (WASH)
21 t complex and the endosomal Arp2/3 activator Wiskott-Aldrich syndrome protein and Scar homolog (WASH)
22 l. and Gomez and Billadeau reveal that WASH (Wiskott-Aldrich syndrome protein and SCAR homolog) activ
24 FAM21, which also binds retromer, within the Wiskott-Aldrich syndrome protein and SCAR homologue (WAS
25 w that the COMMD/CCDC22/CCDC93 (CCC) and the Wiskott-Aldrich syndrome protein and SCAR homologue (WAS
30 dc42 may regulate the activation of neuronal Wiskott-Aldrich syndrome protein and the actin related p
31 ptor that replaces toca-1 to mobilize neural Wiskott-Aldrich syndrome protein and the Arp2/3 complex.
32 hat drive actin polymerization such as WASp (Wiskott-Aldrich syndrome protein) and HS1 (hematopoietic
33 mbly protein Las17 (a yeast homolog of human Wiskott-Aldrich syndrome protein) and participate in the
34 ns of increased detergent stringency Sam 68, Wiskott-Aldrich Syndrome protein, and hnRNP-K, but not C
35 owever was slower and required intact actin, Wiskott-Aldrich syndrome protein, and microtubule functi
36 kott-Aldrich syndrome protein (WASP), neural Wiskott-Aldrich syndrome protein, and WASP-interacting p
38 ctin dynamics through the Nck/N-WASp (neural Wiskott-Aldrich syndrome protein)/Arp2/3 pathway is esse
39 to which we apply these ideas is that of the Wiskott-Aldrich Syndrome Proteins as activators of actin
40 belson tyrosine kinase) and N-WASP (neuronal Wiskott-Aldrich Syndrome Protein) at the cell edge witho
41 previously that the yeast orthologue of the Wiskott-Aldrich Syndrome protein, Bee1/Las17p, and the t
44 cell division cycle 42, which, together with Wiskott-Aldrich syndrome protein, coordinates F-actin re
45 for actin binding (profilin or the WH2 from Wiskott-Aldrich syndrome protein) decrease full-length I
48 ition, Arp3-silenced cells expressing neural Wiskott-Aldrich syndrome protein-derived peptides that i
49 surface receptors was rapid and depended on Wiskott-Aldrich syndrome protein-driven actin polymeriza
50 ely in hematopoietic stem cells, and because Wiskott-Aldrich syndrome protein exerts a strong selecti
51 Recombinant Arc40 bound the VCA domain of Wiskott-Aldrich syndrome protein family activators at a
53 et breast cancer development and metastasis, Wiskott-Aldrich syndrome protein family member 3 (Wasf3)
54 xin A1 and GDE3 from the plasma membrane via Wiskott-Aldrich syndrome protein family member 3 (WAVE3)
57 EspF(U) potently activates the host WASP (Wiskott-Aldrich syndrome protein) family of actin-nuclea
58 proteins 2/3) complex is activated by WASP (Wiskott-Aldrich syndrome protein) family proteins to nuc
59 be mediated by the protein Scar/WAVE (WASP (Wiskott-Aldrich syndrome protein)-family verprolin homol
60 regulator of actin dynamics called the WAVE (Wiskott-Aldrich syndrome protein-family verprolin homolo
66 drich syndrome is caused by mutations of the Wiskott-Aldrich syndrome protein gene, which codes for a
68 he discovery of unique functional domains of Wiskott-Aldrich syndrome protein has been instrumental i
69 ress made in dissecting the functions of the Wiskott-Aldrich syndrome protein has direct implications
70 g a proline-rich domain and an actin-binding Wiskott-Aldrich syndrome protein homology 2 (WH2) domain
71 despite having only a single G-actin-binding Wiskott-Aldrich syndrome protein Homology 2 (WH2) domain
72 length short (SALS) is a recently identified Wiskott-Aldrich syndrome protein homology 2 (WH2) domain
73 y relies on a cluster of three actin-binding Wiskott-Aldrich syndrome protein homology 2 (WH2) domain
74 autoregulatory domain (DAD) that resembles a Wiskott-Aldrich syndrome protein homology 2 (WH2) sequen
75 tant manner, bound actin monomer via a WASP (Wiskott-Aldrich syndrome protein) homology 2 domain, bou
76 variable was the presence or absence of the Wiskott-Aldrich syndrome protein in the lymphoid cells f
77 he actin regulatory protein N-WASP (neuronal Wiskott-Aldrich syndrome protein) in which the "output"
79 s includes Wiskott-Aldrich syndrome protein, Wiskott-Aldrich syndrome protein-interacting protein, co
85 nucleation-promoting protein N-WASP (Neural Wiskott-Aldrich syndrome protein) is up-regulated in bre
86 toskeletal protein with sequence homology to Wiskott-Aldrich syndrome protein, is required for the fi
87 mphiphysin-RVS-domain protein Rvs167 and the Wiskott-Aldrich syndrome protein Las17 at the point of p
89 such as integrin beta1, cortactin, neuronal Wiskott-Aldrich syndrome protein, membrane type 1 metall
90 sion required actin polymerization, neuronal Wiskott-Aldrich syndrome protein, myosin II and Rho GTPa
91 stimulated phosphoprotein (VASP), and neural Wiskott Aldrich syndrome protein (N-WASP) are present at
92 study, we investigated the role of neuronal Wiskott Aldrich syndrome protein (N-WASP) in modulating
93 tein c-Abl interactor 1 (Abi1) with neuronal Wiskott-Aldrich syndrome protein (N-WASP) (an actin-regu
94 complex was necessary for cdc42 and neuronal Wiskott-Aldrich syndrome protein (N-WASP) activation, ac
95 spatial and temporal regulation of neuronal Wiskott-Aldrich syndrome protein (N-WASP) activity in li
96 localization of the actin-regulatory neural Wiskott-Aldrich syndrome protein (N-WASP) and actin-rela
97 nts in the actin regulatory protein neuronal Wiskott-Aldrich syndrome protein (N-WASP) and an SH2 dom
99 474/1 leads to recruitment of Nck and neural Wiskott-Aldrich syndrome protein (N-WASP) and strong act
100 c42), the nucleation-promoting factor neural Wiskott-Aldrich syndrome protein (N-WASP) and the actin
102 zation is mediated by activation of neuronal Wiskott-Aldrich syndrome protein (N-WASp) and the Arp (a
103 iprotein compound containing CrkII, neuronal Wiskott-Aldrich Syndrome Protein (N-WASP) and the Arp2/3
104 gulators of actin cytoskeleton dynamics, the Wiskott-Aldrich syndrome protein (N-WASP) and the Arp2/3
105 ole of the actin nucleation promoters neural Wiskott-Aldrich syndrome protein (N-WASP) and WAVE2 in c
106 and Src family tyrosine kinases, and neural Wiskott-Aldrich syndrome protein (N-WASP) but not the Ar
107 indicates that the nuclear localized neural Wiskott-Aldrich syndrome protein (N-WASP) can induce de
110 we showed that S. flexneri relies on neural Wiskott-Aldrich Syndrome protein (N-WASP) in HT-29 cells
111 f hyaluronan (HA) and CD44 with the neuronal Wiskott-Aldrich syndrome protein (N-WASP) in regulating
112 f the actin-regulatory protein called neural Wiskott-Aldrich syndrome protein (N-WASP) interacting wi
116 er suggests that the actin-regulatory neural Wiskott-Aldrich syndrome protein (N-WASP) mediates the e
118 actin nucleating endocytic protein neuronal Wiskott-Aldrich syndrome protein (N-WASP) to facilitate
119 of the nucleation-promoting factor Neuronal Wiskott-Aldrich Syndrome Protein (N-WASp) to inactive, s
121 n activation of the Arp2/3 complex by neural Wiskott-Aldrich Syndrome protein (N-WASP) via Grb2 and N
122 I, synaptojanin, synapsin I, and the neural Wiskott-Aldrich syndrome protein (N-WASP), a stimulator
124 -mediated EGFR signaling up-regulated neural Wiskott-Aldrich syndrome protein (N-WASP), an actin nucl
125 acted with lacrimal acinar dynamin, neuronal Wiskott-Aldrich Syndrome protein (N-WASP), and synaptoja
126 ched in actin-related protein 3 and neuronal Wiskott-Aldrich syndrome protein (N-WASP), and their ass
127 in-binding and -polymerizing proteins neural Wiskott-Aldrich syndrome protein (N-WASP), cortactin, an
128 d the actin nucleation pathway member Neural Wiskott-Aldrich syndrome protein (N-WASP), form during a
129 ockout approach to assess the role of neural Wiskott-Aldrich syndrome protein (N-WASP), the ubiquitou
130 s, we have analysed the dynamics of neuronal Wiskott-Aldrich syndrome protein (N-WASP), WASP-interact
132 nce microscopy, we demonstrate that neuronal Wiskott-Aldrich syndrome protein (N-WASP), which is coex
134 M. avium led to the recruitment of neuronal Wiskott-Aldrich syndrome protein (N-WASp), which was not
140 onse to signals that locally activate neural Wiskott-Aldrich-syndrome protein (N-WASP) and the Arp2/3
142 ed that C. parvum activates the Cdc42/neural Wiskott-Aldrich syndrome protein network in host cells r
143 the microtubule-organizing center, F-actin, Wiskott-Aldrich syndrome protein, nor proline rich tyros
144 the actin regulatory proteins Las17p (yeast Wiskott-Aldrich syndrome protein) or Arp2/3, or deletion
145 became more tightly associated with neuronal Wiskott-Aldrich syndrome protein, promoting actin-relate
148 ASH is an endosomal protein belonging to the Wiskott-Aldrich syndrome protein superfamily that partic
149 ve studies of patients with mutations of the Wiskott-Aldrich syndrome protein unequivocally demonstra
151 The direct interaction of Skap2 with the Wiskott-Aldrich syndrome protein via its SH3 domain is c
152 ctin dynamics and Ag transport by activating Wiskott-Aldrich syndrome protein via Vav and phosphatidy
155 to mutations of the X-chromosome gene WASP (Wiskott-Aldrich syndrome protein), was characterized ori
157 ed lipid bilayers coated with purified yeast Wiskott Aldrich Syndrome Protein (WASP), an endocytic ac
159 3 complex also interacts with members of the Wiskott-Aldrich syndrome protein (WASP) [8] family - Sca
165 ctivation, when it is able to associate with Wiskott-Aldrich syndrome protein (WASp) and the actin fi
167 tion by activating the pathway involving the Wiskott-Aldrich syndrome protein (WASP) and the actin-re
169 namics are controlled by Arp2/3 complex, the Wiskott-Aldrich syndrome protein (WASp) and the related
170 in polymerization through Arp2/3 nucleation, Wiskott-Aldrich syndrome protein (WASP) and WASP family
171 ing proteins were the actin binding proteins Wiskott-Aldrich syndrome protein (WASP) and WASP-interac
173 actin polymerization in pseudopods, whereas Wiskott-Aldrich syndrome protein (WASP) assembles actin
174 s) induces localized activation of Cdc42 and Wiskott-Aldrich Syndrome protein (WASP) at the immune sy
175 the SRC homology 3 (SH3) domain and impairs Wiskott-Aldrich syndrome protein (WASP) binding, but it
176 tative model of allosteric regulation of the Wiskott-Aldrich syndrome protein (WASP) by the Rho GTPas
177 the formation of endogenous Lck-Dlgh1-Zap70-Wiskott-Aldrich syndrome protein (WASp) complexes in whi
178 w that the actin nucleation-promoting factor Wiskott-Aldrich syndrome protein (WASP) contributes to m
180 ry immune deficiency disorder resulting from Wiskott-Aldrich syndrome protein (WASp) deficiency.
181 efined by either WAS gene mutation or absent Wiskott-Aldrich syndrome protein (WASP) expression or a
182 which are caused by WAS mutations affecting Wiskott-Aldrich syndrome protein (WASp) expression or ac
183 rimary immunodeficiency caused by absence of Wiskott-Aldrich syndrome protein (WASP) expression, resu
188 d by different human proteins, including the Wiskott-Aldrich syndrome protein (WASp) family members.
189 the actin cytoskeleton through activation of Wiskott-Aldrich syndrome protein (WASP) family members.
191 w that mycolactone operates by hijacking the Wiskott-Aldrich syndrome protein (WASP) family of actin-
193 everal recent studies have demonstrated that Wiskott-Aldrich syndrome protein (WASP) family proteins
194 esponse to upstream signals, proteins in the Wiskott-Aldrich Syndrome protein (WASP) family regulate
196 , and acidic (VCA) region of proteins in the Wiskott-Aldrich syndrome protein (WASp) family, Arp2/3 c
201 WAS and XLT are caused by mutations of the Wiskott-Aldrich syndrome protein (WASP) gene which encod
203 No defects related to deficiency of the Wiskott-Aldrich Syndrome protein (WASp) have been descri
205 f formins, known filament nucleators use the Wiskott-Aldrich syndrome protein (WASP) homology 2 (WH2
218 previously that tyrosine phosphorylation of Wiskott-Aldrich syndrome protein (WASP) is important for
221 ucleation by Arp2/3 complex activated by the Wiskott-Aldrich syndrome protein (WASP) or Scar protein;
224 ed individuals reveals that mutations in the Wiskott-Aldrich syndrome protein (WASP) result in struct
225 utation (Leu270Pro) in the gene encoding the Wiskott-Aldrich syndrome protein (WASp) resulting in an
227 fic mutations in the human gene encoding the Wiskott-Aldrich syndrome protein (WASp) that compromise
228 LN) is caused by activating mutations in the Wiskott-Aldrich syndrome protein (WASP) that result in a
229 Here we have used cells deficient in the Wiskott-Aldrich syndrome protein (WASp) to demonstrate t
230 etal dysfunction caused by deficiency of the Wiskott-Aldrich syndrome protein (WASp) to explore the c
231 r receptor-bound protein 2 (Grb2) and to the Wiskott-Aldrich syndrome protein (WASp) to form a hetero
235 ds through its BAR domain and interacts with Wiskott-Aldrich Syndrome Protein (WASP) via its SRC homo
236 roteins involved in actin dynamics including Wiskott-Aldrich syndrome protein (WASp) were regulated b
237 ed via the phagocyte-specific kinase Hck and Wiskott-Aldrich syndrome protein (WASP), 2 major regulat
238 we demonstrated that ACK1 phosphorylates the Wiskott-Aldrich syndrome protein (WASP), a Cdc42 effecto
239 hat the PSTPIP SH3 domain interacts with the Wiskott-Aldrich syndrome protein (WASP), a cytoskeletal
240 s, develop in patients and mice deficient in Wiskott-Aldrich syndrome protein (WASP), a hematopoietic
241 protein, Bee1, exhibits sequence homology to Wiskott-Aldrich syndrome protein (WASP), a human protein
242 tients bearing inactivating mutations in the Wiskott-Aldrich syndrome protein (WASP), a key regulator
243 onsisting of WASp-interacting protein (WIP), Wiskott-Aldrich syndrome protein (WASp), actin, and myos
244 o the cytoskeleton through its effector, the Wiskott-Aldrich syndrome protein (WASP), activation of w
245 ynapse through focal nucleation of actin via Wiskott-Aldrich syndrome protein (WASP), and contraction
246 f, required an activating factor such as the Wiskott-Aldrich syndrome protein (WASP), and might exhib
247 rcent of natural killer (NK) cells expressed Wiskott-Aldrich syndrome protein (WASP), and NK cells co
250 proline-rich protein that interacts with the Wiskott-Aldrich syndrome protein (WASP), from BJAB cell
251 teractions with a wide network of molecules: Wiskott-Aldrich syndrome protein (WASp), Grb2, ribosomal
253 se pulldown analyses show Robo4 binding to a Wiskott-Aldrich syndrome protein (WASP), neural Wiskott-
255 we provide evidence that Kit signals through Wiskott-Aldrich syndrome protein (WASP), the central hem
256 e B (PhyB) and fused the Cdc42 effector, the Wiskott-Aldrich Syndrome Protein (WASP), to the light-de
259 hat branching occurs when Arp2/3 is bound to Wiskott-Aldrich syndrome protein (WASP), which is in tur
260 racts through its SH3 domains with the human Wiskott-Aldrich syndrome protein (WASp), which plays a r
262 edly reduced in macrophages deficient in the Wiskott-Aldrich syndrome protein (WASP), which still con
264 for the assembly of filopodia-like bundles: Wiskott-Aldrich syndrome protein (WASP)-coated beads, ac
265 tients with the Wiskott-Aldrich syndrome and Wiskott-Aldrich syndrome protein (WASP)-deficient mice,
268 P) intracellular domain (AICD) downregulates Wiskott-Aldrich syndrome protein (WASP)-family verprolin
272 s, where it was activated by p78/83, a viral Wiskott-Aldrich syndrome protein (WASP)-like protein.
273 e, Sos-activated Ras signaling and the human Wiskott-Aldrich Syndrome protein (WASp)-mediated actin c
284 inhibit the ability of Nwk-SH3a to activate Wiskott-Aldrich syndrome protein (WASp)/actin related pr
285 mparable to podosomes in the localization of Wiskott-Aldrich syndrome protein (WASP)/matrix metallopr
286 Nucleation-promoting factors (NPFs) of the Wiskott-Aldrich syndrome protein (WASP)/Scar family are
289 lex must bind ATP, protein activators [e.g., Wiskott-Aldrich syndrome protein (WASp)], and the side o
292 ycolactone-mediated activation of neural (N) Wiskott-Aldrich syndrome proteins (WASP) induces defects
293 /3 complex activation domain (WCA) of Las17 (Wiskott-Aldrich syndrome protein [WASp] homologue) fused
294 complex and in Bee1p/Las17p, a member of the Wiskott-Aldrich syndrome protein(WASP) family, lead to a
298 the DSH3PX1 SH3 domain interaction with the Wiskott-Aldrich Syndrome protein while enabling DSH3PX1
300 lation increased the association of neuronal Wiskott-Aldrich syndrome protein with Cdc42 and the Arp2